RPG Life Sciences invests in API business, eyes 'China-plus one' advantage

6 September 2026 at 6:38 pmHyperFast News

#RPG Life Sciences #API #China-plus one strategy #Harsh Goenka #Drug ingredients #Indian manufacturers

Summary

RPG Life Sciences is investing in building a drug-ingredients business, anticipating that the global shift away from reliance on China will benefit Indian manufacturers.

RPG Life Sciences invests in API business, eyes 'China-plus one' advantage

Related news

Select what you want to create

Image Post

Prompt to Post

Audio Post

Video Post

Multi-News Carousel

Upload and Schedule

Blog Post

AI Anchor Video

Newsroom FAQs